Wockhardt planning to raise funds via various sources

22 Apr 2019 Evaluate

Wockhardt is planning to raise funds by issue of Equity Shares, Global Depository Receipts, American depository receipts, Foreign Currency Convertible Bonds, fully convertible debentures, partly convertible debentures, preference shares convertible into Equity Shares, and/ or any other financial instruments convertible into Equity Shares (including warrants, or otherwise, in registered or bearer form) and/ or any security convertible into equity Shares, combination of any of the aforementioned securities by way of one or more public and/ or private offerings, Qualified Institutions Placement and/ or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law.

The meeting of the Board of Directors of the Bank is scheduled to be held on May 06, 2019, to consider the same.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1445.75 -12.80 (-0.88%)
02-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1878.00
Dr. Reddys Lab 1373.70
Cipla 1537.55
Lupin 2396.30
Zydus Lifesciences 990.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.